Last reviewed · How we verify
Polyneuropathy in amyloidosis
Approved treatments
- Onpattro · Alnylam Pharmaceuticals
Onpattro works by silencing the production of abnormal TTR protein using small interfering RNA. - Onpattro · Alnylam Pharmaceuticals
Onpattro works by silencing the production of abnormal TTR protein through RNA interference.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Polyneuropathy in amyloidosis patent landscape — cliff calendar, originator estates, attackable patents
- Polyneuropathy in amyloidosis treatment landscape brief
- Polyneuropathy in amyloidosis treatment updates RSS
Frequently asked questions about Polyneuropathy in amyloidosis
What drugs treat Polyneuropathy in amyloidosis?
Tracked treatments include Onpattro.
What is the treatment for Polyneuropathy in amyloidosis?
Standard treatment for Polyneuropathy in amyloidosis includes Onpattro. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Polyneuropathy in amyloidosis patent cliff · Polyneuropathy in amyloidosis CI report
- Treatment: Onpattro · Alnylam Pharmaceuticals
- Treatment: Onpattro · Alnylam Pharmaceuticals
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing